Fierce Biotech September 28, 2022
After Pfizer, AstraZeneca, Teva and Merck KGaA backed an Israeli startup incubator looking to wield artificial intelligence in the discovery and development of new drugs, they’re now celebrating the launch of their first company.
AION Labs—described as an alliance of global pharmas, tech leaders and investors that launched late last year—is raising the curtain on OMEC.AI, a venture tasked with employing machine learning to help predict which drug candidates will be most likely to succeed in human clinical trials and which will not.
The Israel Innovation Authority approved and financially boosted OMEC.AI’s formation, the companies said in a release. Besides its pharma backers, AION is also backed by the Israel Biotech Fund Amazon Web Services...
Today's Sponsors
Today's Sponsor